Ticker League

Spruce Biosciences (SPRB) Free Cash Flow Bridge

Pinpoint what moved Spruce Biosciences's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

TTM

FCF YoY

+45.39%

OCF YoY

+45.41%

Capex Change

+10.0K

FCF Conversion Δ

Free cash flow bridge for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $24.39M

FCF bridge breakdown for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow−$53.73M
  • Operating Cash Flow$24.40M
  • Capital Expenditure−$10.00K
  • Free Cash Outflow−$29.34M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation